scispace - formally typeset
N

Nora D. Volkow

Researcher at National Institute on Drug Abuse

Publications -  1038
Citations -  121498

Nora D. Volkow is an academic researcher from National Institute on Drug Abuse. The author has contributed to research in topics: Dopamine & Addiction. The author has an hindex of 165, co-authored 958 publications receiving 107463 citations. Previous affiliations of Nora D. Volkow include National Institutes of Health & North Shore University Hospital.

Papers
More filters
Journal ArticleDOI

Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review

TL;DR: To inform the political discourse with scientific evidence, the literature was reviewed to identify what is known and not known about the effects of cannabis use on human behavior, including cognition, motivation, and psychosis.
Journal ArticleDOI

The dopamine motive system: implications for drug and food addiction.

TL;DR: Dopamine contributes to addiction and obesity through its differentiated roles in reinforcement, motivation and self-regulation, referred to here as the 'dopamine motive system', which, if compromised, can result in increased, habitual and inflexible responding.
Journal ArticleDOI

Collision of the COVID-19 and Addiction Epidemics.

TL;DR: The risks of the collision of the COVID-19 and addiction epidemics are described, which could put at risk those who have opioid use disorder and methamphetamine use disorder.
Journal ArticleDOI

Drug addiction: the neurobiology of behaviour gone awry.

TL;DR: Recent studies have shown that repeated drug use leads to long-lasting changes in the brain that undermine voluntary control, and new knowledge of how environmental, genetic and developmental factors contribute to addiction should bring about changes in the authors' approach to the prevention and treatment of addiction.
Journal ArticleDOI

The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies.

TL;DR: This model focuses mostly on findings from PET studies of the brain DA system, but it is evident that other neurotransmitters are involved and that a better understanding of their roles in addiction would expand the options for therapeutic targets.